Distribution of company announcements to the professional platforms, finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems.
NattoPharma (OSL:NATTO) NattoPharma ASA and PL Thomas proudly announce that NattoPharma's natural vitamin K2 product, MenaQ7(TM), has received the prestigious 2008 Frost & Sullivan Product Innovation of the Year Award in the North American Vitamin market. According to Frost & Sullivan "The award is in recognition of the company's unique capability to develop natural vitamin K2 as MenaQ7(TM) with established and proven bone and heart health benefits. Owing to its natural form coupled with superb bioavailability, MenaQ7 obtained excellent market acceptance."
Newly recognized natural Vitamin K2 is amongst the most interesting new offerings in the vitamin market in recent years. Its function is unique among other vitamins and its beneficial health effects have been clearly documented. The role of vitamin K2 has for the past decade been linked to two of the most important health issues, osteoporosis and cardiovascular disease. This link specifically centers on calcium utilization -- implying that in the absence of adequate vitamin K, concurrent arterial calcification and osteoporosis may occur. K vitamins are essential to activate proteins involved in calcium metabolism.
"We are honored to receive this award from Frost & Sullivan, recognized as a global market analysis and solution leader," commented NattoPharma CEO Egil Greve. "Vitamin K2 has been consumed in Japan for centuries through the food dish natto, however the beneficial health effects have only recently become known in the western world. A major challenge is to educate physicians as well as the public about these health benefits, and NattoPharma has committed itself to do this in a scientific manner."
Greve continued, "We are investing heavily in Research & Development and we base all our marketing on the solid scientific documentation of our safe and highly effective natural vitamin K2 product, MenaQ7(TM). We find it very encouraging that this investment, accompanied with NattoPharma's and our US distributor PL Thomas' intense marketing to educate the market about this unique ingredient, has been honored with the Award."
Paul Flowerman, President of PL Thomas added "We are most pleased to have MenaQ7 recognized as an innovative ingredient. It is truly fulfilling to be able to provide a natural product with real health benefits at all stages of one's life. MenaQ7 provides an essential vitamin for neonatal care, for healthy growing and mature bones, and to ensure proper utilization of calcium for cardiovascular health as we age."
The Frost & Sullivan Product Innovation of the Year Award is presented each year to the company that has demonstrated excellence in new products and technologies within its industry.
The recipient of this Award has excelled based on one or more of the following criteria: * Significance of new product(s) in its industry * Competitive advantage of new product(s) in its industry * Product innovation in terms of unique or revolutionary technology * Product acceptance in the marketplace * New products value-added services provided to customers * Number of competitors with similar product(s)
# # #
For more information, contact Egil Greve at +47 951 09 565
